Evidence map›Paper›PMID 40837111›Full record

ReviewJournal of the Endocrine Society2025

Pregnancy and Lactation Associated Bone Fragility.

Christopher S Kovacs

Abstract readReview
In one paragraph

Review in Journal of the Endocrine Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Letter of response to "Postpartum timing of teriparatide initiation and BMD response in pregnancy‑ and lactation‑associated osteoporosis: an observational study".Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
  2. Review
  3. Article
  4. Bone health across the lifespan in African populations affected by HIV.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Christopher S KovacsFaculty of Medicine, Memorial University of Newfoundland, Health Sciences Centre, Newfoundland, Canada A1B 3V6.ORCID https://orcid.org/0000-0002-5219-9993

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The skeleton is a storehouse of mineral that can be borrowed from in times of need, such as for reproduction. Skeletal resorption is normally modest during pregnancy but can be excessive when dietary calcium intake or absorption are insufficient for maternal and fetal needs. In contrast, substantial skeletal resorption is hormonally programmed to occur during lactation, with a loss of 5% to 10% of bone density from the spine over the first 6 months, independent of dietary calcium intake. The maternal skeleton is the main source of calcium in milk. Normally bone resorption during reproduction is without clinical consequences because the skeleton is restored to its prior mineral content and strength after weaning, such that parity and lactation are not risk factors for osteoporosis. However, bone strength is transiently reduced particularly during lactation, and can rarely lead to fragility fractures, especially if the skeleton was not normal before pregnancy. Women can present with fragility fractures during pregnancy but more often during lactation, sometimes with a frightening cascade of 5 to 10 vertebral compression fractures. This mini-review covers the epidemiology, pathophysiology, diagnostic approaches, and treatment considerations for this condition. Pharmacotherapy is often given in a desperate effort to do something, using agents that are not indicated in premenopausal women. The skeleton appears to recover, even in women who have fractured, such that it remains uncertain as to whether pharmacotherapy is necessary. Randomized trials are needed to determine when and in whom pharmacotherapy is needed, and which agent(s) might be preferable.

Indexed as

bisphosphonateslactationosteoporosisparathyroid hormone–related proteinpregnancyteriparatide

Identifiers

PMID40837111
PMCPMC12362253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.